We previously identified that high-expressing myocyte enhancer factor-2A (MEF2A) cardiac-specific transgenic mice develop heart failure by 3 weeks of age and showed induction of Mg29 mRNA expression21, a known skeletal muscle-specific gene10. The gene discussed is SYPL2; the disease is heart failure.